Jonathan Goldman

Jonathan Goldman, MD MBA is an accomplished medical professional and business leader currently serving as the Chief Executive Officer of Clinical ink and a Board Member for Avalo Therapeutics. With extensive experience in the healthcare sector, Goldman has held key positions including President of Goldman Pharma Consulting and Chief Executive Officer of Abzena and Aptuit. Goldman's academic contributions include a role as a Guest Lecturer at the University of California, Berkeley, Haas School of Business, and a long-term position as Associate Clinical Professor of Medicine in the Division of Cardiology at the University of California, San Francisco. Goldman's educational background encompasses degrees in Immunology and Medicine from the University of London and Queen Mary University, as well as Executive MBAs from Columbia Business School and the University of California, Berkeley.